|
|
|
|
150 !
|
Tue, 8/10/2021,
10:00 AM -
11:50 AM
|
Virtual
|
|
COVID-19 Vaccine Statistics: A Reflection on a Year at Warp Speed — Invited Papers
|
|
Biometrics Section, Biopharmaceutical Section, Section on Statistics in Epidemiology
|
|
Organizer(s): David Benkeser, Emory University
|
|
Chair(s): David Benkeser, Emory University
|
|
10:05 AM
|
US Regulatory Considerations for COVID-19 Vaccine Trials
John Scott, FDA / CBER
|
|
10:25 AM
|
The Burden of Selecting a Primary Efficacy Endpoint: Consideration of a COVID-19 Burden of Disease Endpoint
Jonathan V Hartzel, Merck & Co., Inc.; Devan V Mehrotra, Merck & Co., Inc.
|
|
10:45 AM
|
Understanding the Effects of COVID-19 Vaccines on Reducing Secondary Transmission
Holly Janes, Fred Hutchinson Cancer Research Center
|
|
11:05 AM
|
Inference for Natural Mediation Effects Under Case-Cohort Sampling with Applications in Identifying COVID-19 Vaccine Correlates of Protection
Ivan Diaz, Weill Cornell Medical College
|
|
11:25 AM
|
Discussant: Dean Follmann, NIH
|
|
11:45 AM
|
Floor Discussion
|
